{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"EPA-HQ-OPPT-2003-0006\" sorted by posted_date descending", "rows": [["EPA-HQ-OPPT-2003-0006-0412", "EPA", "EPA-HQ-OPPT-2003-0006", "100-01-6, Aceto Commitment to Test, 12-30-09", "Supporting & Related Material", "Letter", "2013-01-25T05:00:00Z", 2013, 1, null, null, "2013-01-25T16:26:33Z", null, 0, 0, "09000064811a5575"], ["EPA-HQ-OPPT-2003-0006-0411", "EPA", "EPA-HQ-OPPT-2003-0006", "TSCA Chemical Testing; Receipt of Test Data", "Supporting & Related Material", "Publication - Previous/Related FR Notice", "2011-07-19T04:00:00Z", 2011, 7, null, null, "2013-01-15T15:44:02Z", null, 0, 0, "0900006480ec62d1"], ["EPA-HQ-OPPT-2003-0006-0410", "EPA", "EPA-HQ-OPPT-2003-0006", "Toxic Substances Control Act Chemical Testing; Receipt of Test Data", "Notice", null, "2011-06-29T04:00:00Z", 2011, 6, null, null, "2025-07-03T15:05:16Z", "2011-16183", 0, 0, "0900006480eb64a4"], ["EPA-HQ-OPPT-2003-0006-0409", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Office of Pollution, Prevention and Toxics, Document Control Office, USEPA, from Joan P. Daniels, Vice President, Nippon Paint (America) Corp.", "Supporting & Related Material", "Letter, Memorandum, Email", "2011-03-02T05:00:00Z", 2011, 3, null, null, "2013-01-15T15:44:02Z", null, 0, 0, "0900006480bfbfaf"], ["EPA-HQ-OPPT-2003-0006-0408", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Document Control Office, Office of Pollution Prevention and Toxics, USEPA, from Suhey Francisco, Regulatory Affairs Specialist-Environmental, Heath, Safety and Regulatory Affairs, ACETO Corporation", "Supporting & Related Material", "Letter, Memorandum, Email", "2010-08-18T04:00:00Z", 2010, 8, null, null, "2010-08-18T17:25:43Z", null, 0, 0, "0900006480b2e168"], ["EPA-HQ-OPPT-2003-0006-0403", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of Percutaneous Absorption and Cutaneous Disposition of [14C]-Diacetone Alcohol In Vitro in Human Skin (123-42-2)", "Supporting & Related Material", "Study", "2010-05-14T04:00:00Z", 2010, 5, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064809a8a78"], ["EPA-HQ-OPPT-2003-0006-0402", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of Percutaneous Absorption and Cutaneous Disposition of [14C]-Dicyclopentadiene In Vitro in Human Skin (77-73-6)", "Supporting & Related Material", "Study", "2010-05-14T04:00:00Z", 2010, 5, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064809a867a"], ["EPA-HQ-OPPT-2003-0006-0405", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Simone A. Miller, Corporate Director, Aceto Corporation from Jim Willis, Director, Chemical Control Division, OPPTS, USEPA", "Supporting & Related Material", "Letter, Memorandum, Email", "2010-05-14T04:00:00Z", 2010, 5, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064809c003c"], ["EPA-HQ-OPPT-2003-0006-0407", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Simone A. Miller, Corporate Director, Aceto Corporation from Jim Willis, Director, Chemical Control Division, OPPTS, USEPA", "Supporting & Related Material", "Letter, Memorandum, Email", "2010-05-14T04:00:00Z", 2010, 5, null, null, "2013-01-15T15:44:02Z", null, 0, 0, "0900006480aab555"], ["EPA-HQ-OPPT-2003-0006-0406", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA from Karina Gilje, Regulatory Manager, Univar USA Inc., re: Application for Exemption from Test Rule", "Supporting & Related Material", "Letter, Memorandum, Email", "2010-05-14T04:00:00Z", 2010, 5, null, null, "2013-01-15T15:44:02Z", null, 0, 0, "09000064809cb723"], ["EPA-HQ-OPPT-2003-0006-0404", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of Determination of the In Vitro Absorption Rate of Diphenylamine (122-39-4)", "Supporting & Related Material", "Study", "2010-05-14T04:00:00Z", 2010, 5, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064809b584a"], ["EPA-HQ-OPPT-2003-0006-0401", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA from Suhey Francisco, Regulatory Affairs Specialist, ACETO Corporation, re: Application for Exemption from Test Rule", "Supporting & Related Material", "Letter, Memorandum, Email", "2009-09-28T04:00:00Z", 2009, 9, null, null, "2013-01-15T15:44:02Z", null, 0, 0, "0900006480a0df69"], ["EPA-HQ-OPPT-2003-0006-0392", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of In Vitro Dermal Absorption Rate Testing for 2-Nitropropane (79-46-9)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd28a"], ["EPA-HQ-OPPT-2003-0006-0397", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of In Vitro Dermal Absorption Rate Testing for 1-Nitropropane (108-03-2)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd297"], ["EPA-HQ-OPPT-2003-0006-0391", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of In Vitro Dermal Absorption Rate Testing for Vinylidene Chloride (75-35-4)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd284"], ["EPA-HQ-OPPT-2003-0006-0394", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of In Vitro Dermal Absorption Rate Testing for P-nitrochlorobenzene (100-00-5)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd291"], ["EPA-HQ-OPPT-2003-0006-0395", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of In Vitro Dermal Absorption Rate Testing for Benzyl Chloride (100-44-7)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd293"], ["EPA-HQ-OPPT-2003-0006-0396", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of In Vitro Dermal Absorption Rate Testing for Ethylene Dichloride (107-06-2)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd295"], ["EPA-HQ-OPPT-2003-0006-0389", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA from Scott C. Boito, Product Stewardship Manager, Rhodia, Inc., re: Application for Exemption", "Supporting & Related Material", "Letter, Memorandum, Email", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807a7378"], ["EPA-HQ-OPPT-2003-0006-0398", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of the In Vitro Dermal Absorption of 14C Cyclohexanol Through Human Skin (108-93-0)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd29c"], ["EPA-HQ-OPPT-2003-0006-0390", "EPA", "EPA-HQ-OPPT-2003-0006", "Memorandum to Pam Mosley from Catherine Roman, OPPT, USEPA, re: Review of Dermal Absorption Studies to Add to Docket Number EPA-HQ-OPPT-2003-0006", "Supporting & Related Material", "Letter, Memorandum, Email", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd287"], ["EPA-HQ-OPPT-2003-0006-0393", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of In Vitro Dermal Absorption Rate Testing for Naphthalene (91-20-3)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd28e"], ["EPA-HQ-OPPT-2003-0006-0399", "EPA", "EPA-HQ-OPPT-2003-0006", "Review of Percutaneous Absorption and Cutaneous Disposition of [14C]-Methyl Isoamyl Ketone In Vitro in Human Skin (110-12-3)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd29f"], ["EPA-HQ-OPPT-2003-0006-0400", "EPA", "EPA-HQ-OPPT-2003-0006", "[14C] Catechol: Percutaneous Penetration of [14C] Catechol Through Human Split-thickness Skin Membranes (in vitro) (120-80-9)", "Supporting & Related Material", "Study", "2009-01-22T05:00:00Z", 2009, 1, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064807cd2a1"], ["EPA-HQ-OPPT-2003-0006-0388", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, Chemical Information and Testing Branch, Office of Pollution, Prevention and Toxic, USEPA, from Val Schaeffer, Directorate of Standards and Guidance, Occupational Safety and Health Administration", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-09-24T04:00:00Z", 2008, 9, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064806efe87"], ["EPA-HQ-OPPT-2003-0006-0386", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Lyn Penniman, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for n-Heptane (142-82-5)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-31T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064803f0b8e"], ["EPA-HQ-OPPT-2003-0006-0387", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Lyn Penniman, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for Dipropylene Glycol Methyl Ether (DPGME) (34590-94-8)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-31T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:01Z", null, 0, 0, "09000064803f0b90"], ["EPA-HQ-OPPT-2003-0006-0377", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, USEPA from Simone A. Miller, Corporate Director, EHS and Regulatory Affairs, Aceto Corporation, re: In Vitro Dermal Absorption Rate study of p-nitroaniline", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b73"], ["EPA-HQ-OPPT-2003-0006-0376", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Lyn Penniman, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for Methyl Acetate (79-20-9)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b7e"], ["EPA-HQ-OPPT-2003-0006-0385", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Val Schaeffer, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for Tetrahydrofuran (109-99-9)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b8a"], ["EPA-HQ-OPPT-2003-0006-0379", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Lyn Penniman, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for Propylene Dichloride (78-87-5)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b7c"], ["EPA-HQ-OPPT-2003-0006-0375", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Val Schaeffer, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for Isophorone (78-59-1)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b78"], ["EPA-HQ-OPPT-2003-0006-0383", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Lyn Penniman, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for Pentane (109-66-0)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b87"], ["EPA-HQ-OPPT-2003-0006-0382", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Lyn Penniman, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for Methyl Formate (107-31-3)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b85"], ["EPA-HQ-OPPT-2003-0006-0381", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Val Schaeffer, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for para-Nitroaniline (100-01-6)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2008-03-13T17:53:14Z", null, 0, 0, "09000064803f0b83"], ["EPA-HQ-OPPT-2003-0006-0384", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Lyn Penniman, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for Dimethylacetamide (127-19-5)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b8c"], ["EPA-HQ-OPPT-2003-0006-0378", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Val Schaeffer, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for Acetonitrile (75-05-8)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b75"], ["EPA-HQ-OPPT-2003-0006-0380", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, OPPT, USEPA from Val Schaeffer, Directorate of Standards and Guidance, OSHA, re: Review of In Vitro Dermal Absorption Rate Testing for tert-Butylcatechol (98-29-3)", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-03-13T04:00:00Z", 2008, 3, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803f0b80"], ["EPA-HQ-OPPT-2003-0006-0374", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA from Suhey Francisco, Regulatory Affairs Specialist, Environmental, Health, Safety and Regulatory Affairs, ACETO Corporation, re: Application for Test Rule Requirements", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-01-23T05:00:00Z", 2008, 1, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "090000648039da28"], ["EPA-HQ-OPPT-2003-0006-0373", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA from Gerald A. Dunn, Vice President, Sales, JLM Chemicals, Inc., re: Application for Test Rule Requirements", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-01-23T05:00:00Z", 2008, 1, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "090000648039da26"], ["EPA-HQ-OPPT-2003-0006-0372", "EPA", "EPA-HQ-OPPT-2003-0006", "Interspecies Relationships in Acute Toxicity of Chemicals to Aquatic Organisms", "Supporting & Related Material", "Publication - Copyrighted Materials", "2007-11-20T05:00:00Z", 2007, 11, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064803667b0"], ["EPA-HQ-OPPT-2003-0006-0370", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA from Jean Smith, Vice President, P.H.T. International, Inc., re: Application for Exemption from Testing Requirements", "Supporting & Related Material", "Letter, Memorandum, Email", "2007-10-25T04:00:00Z", 2007, 10, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064802fe8c2"], ["EPA-HQ-OPPT-2003-0006-0371", "EPA", "EPA-HQ-OPPT-2003-0006", "The In Vitro Dermal Absorption of 14C-Cyclohexanol Through Human Skin", "Supporting & Related Material", "Report", "2007-10-25T04:00:00Z", 2007, 10, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064802fe8c6"], ["EPA-HQ-OPPT-2003-0006-0367", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Linda C. Burgert, The Dow Chemical Company from Charles M. Auer, Director, OPPT, USEPA, re: Response to Request for Modifications", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-12-19T05:00:00Z", 2006, 12, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064801ed8e0"], ["EPA-HQ-OPPT-2003-0006-0369", "EPA", "EPA-HQ-OPPT-2003-0006", "Addendum Modification to TSCA Final Test Rule for Diphenylamine (CAS Number 122-39-4)", "Supporting & Related Material", "Other", "2006-12-19T05:00:00Z", 2006, 12, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064801ed8f0"], ["EPA-HQ-OPPT-2003-0006-0368", "EPA", "EPA-HQ-OPPT-2003-0006", "Addendum Modification to TSCA Final Test Rule for Isophorone (CAS Number 78-59-1)", "Supporting & Related Material", "Other", "2006-12-19T05:00:00Z", 2006, 12, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064801ed8ea"], ["EPA-HQ-OPPT-2003-0006-0366", "EPA", "EPA-HQ-OPPT-2003-0006", "Nippon Paint (USA), Inc.'s Application for Exemption for Test Rule Requirements", "Supporting & Related Material", "Application", "2006-11-20T05:00:00Z", 2006, 11, null, null, "2006-11-20T16:59:56Z", null, 0, 0, "09000064801e26e7"], ["EPA-HQ-OPPT-2003-0006-0364", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA, from Karina Gilje, Regulatory Manager, Univar USA, Inc., re: Application for Exemption from Test Rule for n-Heptane", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-14T05:00:00Z", 2006, 11, null, null, "2006-11-14T14:50:50Z", null, 0, 0, "09000064801df2e8"], ["EPA-HQ-OPPT-2003-0006-0365", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA, from Karina Gilje, Regulatory Manager, Univar USA, Inc., re: Application for Exemption from Test Rule for Naphthalene", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-14T05:00:00Z", 2006, 11, null, null, "2006-11-14T14:50:51Z", null, 0, 0, "09000064801df2f5"], ["EPA-HQ-OPPT-2003-0006-0363", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA, from Karina Gilje, Regulatory Manager, Univar USA, Inc, re: Application for Exemption from Test Rule for Chlorobenzene", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-14T05:00:00Z", 2006, 11, null, null, "2006-11-14T14:50:49Z", null, 0, 0, "09000064801df2c5"], ["EPA-HQ-OPPT-2003-0006-0361", "EPA", "EPA-HQ-OPPT-2003-0006", "Facsimile to OPPT Document Control Office, USEPA, from Kenjiro Komori, Unit Head and Product Manager, Sumitomo Corporation of America, re: Exemption Request", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-10-10T04:00:00Z", 2006, 10, null, null, "2006-10-10T15:18:56Z", null, 0, 0, "09000064801d2866"], ["EPA-HQ-OPPT-2003-0006-0362", "EPA", "EPA-HQ-OPPT-2003-0006", "Facsimile to OPPT Document Control Office, USEPA from Kenjiro Komori, Unit Head and Product Manager, Sumitomo Corporation of America, re: Withdrawal of Exemption Request", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-10-10T04:00:00Z", 2006, 10, null, null, "2006-10-10T15:18:56Z", null, 0, 0, "09000064801d286e"], ["EPA-HQ-OPPT-2003-0006-0360", "EPA", "EPA-HQ-OPPT-2003-0006", "Percutaneous Absorption and Cutaneous Disposition of [14C]- Diacetone Alcohol In Vitro in Human Skin", "Supporting & Related Material", "Report", "2006-09-19T04:00:00Z", 2006, 9, null, null, "2006-09-19T15:06:56Z", null, 0, 0, "09000064801c7c44"], ["EPA-HQ-OPPT-2003-0006-0359", "EPA", "EPA-HQ-OPPT-2003-0006", "Final Report: Percutaneous Absorption and Cutaneous Disposition of [14C]-Methyl Isoamyl Ketone In Vitro in Human Skin", "Supporting & Related Material", "Report", "2006-08-24T04:00:00Z", 2006, 8, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064801ba25a"], ["EPA-HQ-OPPT-2003-0006-0358", "EPA", "EPA-HQ-OPPT-2003-0006", "Final Report- Percutaneous Absorption and Cutaneous Disposition of [14C] -Dicyclopentadiene In Vitro in Human Skin", "Supporting & Related Material", "Report", "2006-08-24T04:00:00Z", 2006, 8, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064801ba255"], ["EPA-HQ-OPPT-2003-0006-0357", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA, from John F. Murray, Executive Director, Chlorobenzene Producers Association, re: In Vitro Dermal Absorption Rate Testing for p-Dichlorobenzene and Chlorobenzene", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-08-03T04:00:00Z", 2006, 8, null, null, "2013-01-15T15:44:00Z", null, 0, 0, "09000064801a8f78"], ["EPA-HQ-OPPT-2003-0006-0356", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office and IUR Submissions Coordinator, USEPA, from Lynn E. Rutkowski, Regulatory Affairs Specialist, LANXESS Corporation", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-08-01T04:00:00Z", 2006, 8, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "09000064801a8f75"], ["EPA-HQ-OPPT-2003-0006-0355", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA, from Lynn E. Rutkowski, Regulatory Affairs Specialist, LANXESS Corporation,  re: In Vitro Dermal Absorption Testing of p-Dichlorobenzene and Chlorobenzene", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-07-24T04:00:00Z", 2006, 7, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "09000064801a2db9"], ["EPA-HQ-OPPT-2003-0006-0354", "EPA", "EPA-HQ-OPPT-2003-0006", "Vinylidene Chloride: In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2006-07-18T04:00:00Z", 2006, 7, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "09000064801a093c"], ["EPA-HQ-OPPT-2003-0006-0353", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to William P. Gulledge, Managing Director, American Chemistry Council, from Charles M. Auer, Director, USEPA, OPPT, re: Request for Modification", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-07-18T04:00:00Z", 2006, 7, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "09000064801a093a"], ["EPA-HQ-OPPT-2003-0006-0352", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Document Control Office, Office of Pollution Prevention and Toxics, USEPA, from Lynn E. Rutkowski, Regulatory Affairs Specialist, Lanxess Corporation and Alan J. Olson, Director of Technology, Ferro Polymer Additives, Ferro Corporation", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-06-09T04:00:00Z", 2006, 6, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "0900006480182767"], ["EPA-HQ-OPPT-2003-0006-0351", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Office of Pollution Prevention and Toxics, USEPA, from Scott K. Lusk, Energetic Materials Program Manager, ATK Thiokol", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-06-09T04:00:00Z", 2006, 6, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "0900006480182763"], ["EPA-HQ-OPPT-2003-0006-0349", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Bill Perry, Director, U.S. Occupational Safety and Health Administration, Directorate of Standards and Guidance, Office of Chemical Hazard-Non-Metals, from Greg Schweer, Chief, Chemical Information and Testing Branch, USEPA", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-05-31T04:00:00Z", 2006, 5, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "090000648017b885"], ["EPA-HQ-OPPT-2003-0006-0350", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Bill Perry, Director, U.S. Occupational Safety and Health Administration, Directorate of Standards and Guidance, Office of Chemical Hazards-Non-Metals, from Greg Schweer, Chief, Chemical Information and Testing Branch, USEPA", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-05-31T04:00:00Z", 2006, 5, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "090000648017b887"], ["EPA-HQ-OPPT-2003-0006-0348", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to William P. Gulledge, Managing Director, Ketones Panel, American Chemistry Council, from Charles M. Auer, Director, USEPA, OPPT, re: Request for Modification", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-05-22T04:00:00Z", 2006, 5, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "09000064801767ec"], ["EPA-HQ-OPPT-2003-0006-0347", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Document Control Office, Office of Pollution Prevention and Toxics, USEPA, from William P. Gulledge, Managing Director, Ketones Panel, American Chemical Council, re: Request for Extenson to the Reporting Deadline", "Supporting & Related Material", null, "2006-05-16T04:00:00Z", 2006, 5, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "0900006480171405"], ["EPA-HQ-OPPT-2003-0006-0346", "EPA", "EPA-HQ-OPPT-2003-0006", "Final and Amended Final Reports: Percutaneous Absorption and Cutaneous Disposition of [14C]-Isophorone In Vitro in Human Skin", "Supporting & Related Material", "Report", "2006-05-05T04:00:00Z", 2006, 5, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "090000648016c7e3"], ["EPA-HQ-OPPT-2003-0006-0345", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to William P. Gulledge, Managing Director, American Chemistry Council, from Charles M. Auer, Director, USEPA, OPPT, re: Request for Modifications", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-27T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "090000648016514b"], ["EPA-HQ-OPPT-2003-0006-0343", "EPA", "EPA-HQ-OPPT-2003-0006", "1-Nitropropane: In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2006-04-27T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "0900006480165141"], ["EPA-HQ-OPPT-2003-0006-0344", "EPA", "EPA-HQ-OPPT-2003-0006", "2-Nitropropane: In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2006-04-27T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "0900006480165146"], ["EPA-HQ-OPPT-2003-0006-0331", "EPA", "EPA-HQ-OPPT-2003-0006", "Revocation of TSCA Section 4 Testing Requirements for Certain Chemical Substances", "Rule", "Federal Register Document", "2006-04-12T11:52:09Z", 2006, 4, "2006-04-12T11:52:09Z", "2006-05-13T03:59:59Z", "2013-01-15T15:43:59Z", "06-03491", 0, 0, "090000648015b8b3"], ["EPA-HQ-OPPT-2003-0006-0342", "EPA", "EPA-HQ-OPPT-2003-0006", "Economic Impact Analysis and Small Entity Impact Analysis of the TSCA Section 4(a) Test Rule for 34 Chemicals Targeted for In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "090000648014776b"], ["EPA-HQ-OPPT-2003-0006-0334", "EPA", "EPA-HQ-OPPT-2003-0006", "Memorandum to Greg Schweer, USEPA, from Andrew Mamantov, Exposure Assessment Branch, USEPA re: Handbook of Environmental Degradation Rates", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "090000648014770d"], ["EPA-HQ-OPPT-2003-0006-0337", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, USEPA, from Susan Anderson Lewis, The American Chemistry Council, re: Dermal Absorption Test Rule", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "0900006480147743"], ["EPA-HQ-OPPT-2003-0006-0336", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Office of Pollution Prevention and Toxics, USEPA, from Marc G. Schurger, Director, Product Safety and Health, Eastman Chemical Company, re: In Vitro Dermal Absorption Testing on Methyl Isoamyl Ketone (CAS Number 110-12-3)", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "0900006480147736"], ["EPA-HQ-OPPT-2003-0006-0338", "EPA", "EPA-HQ-OPPT-2003-0006", "Percutaneous Absorption of 5 Glycol Ethers through Human Skin in Vitro", "Supporting & Related Material", "Publication - Copyrighted Materials", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "0900006480147746"], ["EPA-HQ-OPPT-2003-0006-0341", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Susan Anderson Lewis, Managing Director CHEMSTAR, American Chemistry Council, from Charles M. Auer, Director, OPPT, USEPA, re: USEPA review of a recently publish absorption rate study on dipropylene glycol methyl ether", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "0900006480147762"], ["EPA-HQ-OPPT-2003-0006-0333", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Office of Pollution Prevention and Toxics, USEPA, from Robert W. Freerksen, Regulatory Programs Manager, DuPont Chemical Solution Enterprise, re: In Vitro Dermal Absorption Test Rule, Dimethyl Sulfate (CAS No. 77-78-1) Request for Modification of Test Standard", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "09000064801476fd"], ["EPA-HQ-OPPT-2003-0006-0339", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, USEPA, from William G. Perry, Director, Office of Chemical Hazards (Non-Metals), US Occupational Health and Safety Administration (OSHA), re: Two Dermal Absorption Studies", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "0900006480147754"], ["EPA-HQ-OPPT-2003-0006-0335", "EPA", "EPA-HQ-OPPT-2003-0006", "Memorandum to Greg Schweer, from Leonard Keifer", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "0900006480147728"], ["EPA-HQ-OPPT-2003-0006-0340", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Marc G. Schurger, Director, Product Safety and Health, Eastman Chemical Company, from Charles M. Auer, Director, OPPT, USEPA, re: USEPA and OSHA review of the dermal absorption rate study sponsored by the Eastman Chemical Company and conducted by Toxicological Sciences Laboratory", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "090000648014775c"], ["EPA-HQ-OPPT-2003-0006-0332", "EPA", "EPA-HQ-OPPT-2003-0006", "In Vitro Dermal Absorption Rate Testing of Certain Chemicals of Interest to the Occupational Safety and Health Administration; Final Rule", "Supporting & Related Material", "Federal Register Document", "2006-04-12T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "09000064801476f4"], ["EPA-HQ-OPPT-2003-0006-0330", "EPA", "EPA-HQ-OPPT-2003-0006", "Determination of the In Vitro Absorption Rate of Diphenylamine", "Supporting & Related Material", "Report", "2006-04-11T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "0900006480158b0a"], ["EPA-HQ-OPPT-2003-0006-0329", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Bill Perry, U.S. Occupational Safety and Health Administration, Office of Chemical Hazards, re: Reviews of 5 dermal absorption rate studies conducted under TSCA section 4 test rule", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-04-04T04:00:00Z", 2006, 4, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "0900006480154c62"], ["EPA-HQ-OPPT-2003-0006-0328", "EPA", "EPA-HQ-OPPT-2003-0006", "Naphthalene: In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2006-03-27T05:00:00Z", 2006, 3, null, null, "2013-01-15T15:43:59Z", null, 0, 0, "090000648014ce24"], ["EPA-HQ-OPPT-2003-0006-0327", "EPA", "EPA-HQ-OPPT-2003-0006", "TSCA Chemical Testing; Receipt of Test Data", "Notice", "Federal Register Document", "2006-03-15T07:28:56Z", 2006, 3, null, null, "2025-07-03T15:19:39Z", "E6-03586", 0, 0, "0900006480145f1f"], ["EPA-HQ-OPPT-2003-0006-0326", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Scott K. Lusk, Energetic Materials Program Manager, ATK Thiokol, from Charles M. Auer, Director, USEPA, OPPT, re: Request for Modification", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-03-07T05:00:00Z", 2006, 3, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "090000648013f67f"], ["EPA-HQ-OPPT-2003-0006-0325", "EPA", "EPA-HQ-OPPT-2003-0006", "Dipropylene Glycol Methyl Ether: In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2006-02-28T05:00:00Z", 2006, 2, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "090000648013a106"], ["EPA-HQ-OPPT-2003-0006-0324", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA, from William P. Gulledge, Managing Director, Isophorone Dermal Absorption Task Group, American Chemistry Council, re: In Vitro Dermal Absorption Rate Testing Rule for Isophorone (CAS 78-59-1); Request for Extension to the Reporting Deadline", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-02-07T05:00:00Z", 2006, 2, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "0900006480127244"], ["EPA-HQ-OPPT-2003-0006-0322", "EPA", "EPA-HQ-OPPT-2003-0006", "Pentane: In Vitro Dermal Absorption Rate Testing, and n-Heptane: In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2006-01-11T05:00:00Z", 2006, 1, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "090000648010bf4a"], ["EPA-HQ-OPPT-2003-0006-0323", "EPA", "EPA-HQ-OPPT-2003-0006", "Determination of the Percutaneous Absorption of THF, in vitro, Using the Human Cadaver Skin Model", "Supporting & Related Material", "Study", "2006-01-11T05:00:00Z", 2006, 1, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "090000648010e641"], ["EPA-HQ-OPPT-2003-0006-0321", "EPA", "EPA-HQ-OPPT-2003-0006", "TSCA Chemical Testing; Receipt of Test Data", "Notice", "Federal Register Document", "2006-01-10T09:22:41Z", 2006, 1, null, null, "2025-07-03T15:18:52Z", "E6-00100", 0, 0, "090000648010c83f"], ["EPA-HQ-OPPT-2003-0006-0320", "EPA", "EPA-HQ-OPPT-2003-0006", "p- Nitroaniline: In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2006-01-04T05:00:00Z", 2006, 1, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "0900006480103824"], ["EPA-HQ-OPPT-2003-0006-0319", "EPA", "EPA-HQ-OPPT-2003-0006", "Propylene Dichloride: In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2006-01-04T05:00:00Z", 2006, 1, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "0900006480107ad6"], ["EPA-HQ-OPPT-2003-0006-0316", "EPA", "EPA-HQ-OPPT-2003-0006", "p-Xylene: In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Report", "2005-12-20T16:30:13Z", 2005, 12, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "09000064800f8ff6"], ["EPA-HQ-OPPT-2003-0006-0317", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to OPPT Document Control Office, USEPA, from William P. Gulledge, Managing Director, Dermal Absoprtion Task Group, American Chemistry Council, re: Request for an Extension to the Reporting Deadline for Dicyclopentadiene, Diacetone Alcohol, and Methyl Isoamyl Ketone", "Supporting & Related Material", "Letter, Memorandum, Email", "2005-12-20T05:00:00Z", 2005, 12, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "09000064800f8ffc"], ["EPA-HQ-OPPT-2003-0006-0313", "EPA", "EPA-HQ-OPPT-2003-0006", "Letter to Catherine Roman, USEPA from Susan Anderson Lewis, The American Chemistry Council re: Dermal Absorption Test Rule", "Supporting & Related Material", "Letter, Memorandum, Email", "2005-12-20T05:00:00Z", 2005, 12, null, null, "2013-01-15T15:43:57Z", null, 0, 0, "09000064800b67fa"], ["EPA-HQ-OPPT-2003-0006-0310", "EPA", "EPA-HQ-OPPT-2003-0006", "Final Rule Placeholder", "Rule", "Federal Register Document", "2005-12-20T05:00:00Z", 2005, 12, null, null, "2025-07-03T15:18:22Z", null, 0, 0, "09000064800b67ba"], ["EPA-HQ-OPPT-2003-0006-0311", "EPA", "EPA-HQ-OPPT-2003-0006", "Memorandum to Greg Schweer, USEPA from Andrew Mamantov, Exposure Assessment Branch, USEPA re: Handbook of Environmental Degradation Rates", "Supporting & Related Material", "Letter, Memorandum, Email", "2005-12-20T05:00:00Z", 2005, 12, null, null, "2013-01-15T15:43:57Z", null, 0, 0, "09000064800b67d0"], ["EPA-HQ-OPPT-2003-0006-0315", "EPA", "EPA-HQ-OPPT-2003-0006", "Methyl Acetate:  In Vitro Dermal Absorption Rate Testing", "Supporting & Related Material", "Study", "2005-12-20T05:00:00Z", 2005, 12, null, null, "2013-01-15T15:43:58Z", null, 0, 0, "09000064800e9bd4"]], "truncated": false, "filtered_table_rows_count": 402, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "EPA-HQ-OPPT-2003-0006"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006", "results": [{"value": "EPA", "label": "EPA", "count": 402, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&agency_id=EPA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 374, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Rule", "label": "Rule", "count": 25, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&document_type=Rule", "selected": false}, {"value": "Notice", "label": "Notice", "count": 3, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006", "results": [{"value": 2004, "label": 2004, "count": 142, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2004", "selected": false}, {"value": 2003, "label": 2003, "count": 85, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2003", "selected": false}, {"value": 2005, "label": 2005, "count": 81, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2005", "selected": false}, {"value": 2006, "label": 2006, "count": 51, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2006", "selected": false}, {"value": 2008, "label": 2008, "count": 16, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2008", "selected": false}, {"value": 2009, "label": 2009, "count": 13, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2009", "selected": false}, {"value": 2010, "label": 2010, "count": 7, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2010", "selected": false}, {"value": 2007, "label": 2007, "count": 3, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2007", "selected": false}, {"value": 2011, "label": 2011, "count": 3, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2011", "selected": false}, {"value": 2013, "label": 2013, "count": 1, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&posted_year=2013", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&_facet_date=last_modified"}], "next": "2005-12-20T05~3A00~3A00Z,EPA-HQ-OPPT-2003-0006-0315", "next_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OPPT-2003-0006&_next=2005-12-20T05~3A00~3A00Z%2CEPA-HQ-OPPT-2003-0006-0315&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 9.150086902081966, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}